Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria

Transplantation Proceedings

Volumn 43, Issue 10, 2011, Pages 3813-3818

  Hanouneh, I A ^a   MacAron, C ^a   Lopez, R ^a   Aucejo, F ^a   Zein, N N ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADULT; CANCER INVASION; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RECEIVER OPERATING CHARACTERISTIC; RECURRENCE RISK; RECURRENT CANCER; TREATMENT OUTCOME; TUMOR GROWTH; TUMOR VOLUME;

ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; CELL DIFFERENTIATION; CELL PROLIFERATION; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; OHIO; PATIENT SELECTION; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 83655182817     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2011.09.043     Document Type: Conference Paper

References (17)

1. D.M. Parkin, F. Bray, J. Ferlay, P. Pisani Global cancer statistics, 2002 CA Cancer J Clin 55 2005 74
2. H. El-Serag, K.L. Rudolph Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroenterology 132 2007 2557
3. H. El-Serag, A.C. Mason Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 1999 745
4. J.M. Lovet, A. Burroughs, J. Bruix Hepatocellularcarcinoma Lancet 362 2003 1907
5. J. Bruix, M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208
6. V. Mazzaferro, E. Regalia, R. Doci et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 1996 693
7. F.Y. Yao, N.M. Bass, B. Nikolai et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list Liver Transpl 8 2002 873
8. C. Toso, J. Trotter, A. Wei et al. Total tumor volume predicts risk of recurrence following liver transplantation in patients with hepatocellular carcinoma Liver Transpl 14 2008 1107
9. G.B. Klintmalm Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome Ann Surg 228 1998 479
10. S. Jonas, W.O. Bechstein, T. Steinmller et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis Hepatology 33 2001 1080
11. Y. Hoshida, A. Villanueva, M. Kobayashi et al. Gene expression in fixed tissues and outcome in hepatocellular carcinoma N Engl J Med 359 2008 1995
12. J. Jiang, Y. Gusev, I. Aderca et al. Association of microRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival Clin Cancer Res 14 2008 419
13. J.S. Lee, J. Heo, L. Libbrecht et al. A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells Nat Med 12 2006 410
14. J. Bruix, M. Sherman Management of hepatocellular carcinoma Practice Guidelines Committee, American Association for the Study of Liver Diseases Hepatology 42 2005 1208
15. G. Sotiropoulos, M. Malago, E. Molmenti et al. Liver transplantation for hepatocellular carcinoma in cirrhosis: is clinical tumor classification before transplantation realistic? Transplantation 79 2005 483
16. R. Freeman, A. Mithoefer, R. Ruthazer et al. Staging of hepatocellular cancer (HCC) before liver transplantation is suboptimal Am J Transplant 6 Suppl 12 2006 350
17. C. Macaron, I.A. Hanouneh, R. Lopez et al. Total tumor volume predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria Transplant Proc 42 2010 4585